KLK3 and prostate carcinoma: PSA analysis was available for 76 of the 132 patients with prostate cancer (57.6%), with a median value of 1.06ng/mL (range 0.02-19.37ng/mL), and 61 (80.3%) patients had a PSA value below 4 ng/mL.